Design of a Randomised Controlled Trial (RCT) on the effectiveness of a Dutch patient advocacy case management intervention among severely disabled Multiple Sclerosis patients

Klaske Wynia, Coby Annema, Hans Nissen, Jacques De Keyser, Berrie Middel, Klaske Wynia, Coby Annema, Hans Nissen, Jacques De Keyser, Berrie Middel

Abstract

Background: Case management has been suggested as an innovative strategy that facilitates the improvement of a patient's quality of life, reduction of hospital length of stay, optimization of self-care and improvement of satisfaction of patients and professionals involved. However, there is little evidence about the effectiveness of the patient advocacy case management model in clinical practice.Therefore, the objective of our study was to examine the effects of the Dutch patient advocacy case management model for severely disabled Multiple Sclerosis (MS) patients and their caregivers compared to usual care.

Methods/design: In this randomized controlled trial the effectiveness of casemanagement on quality of life of patients and their caregivers, quality of care, service use and economic aspects were evaluated. The primary outcomes of this study were quality of life of MS-patients and caregiver burden of caregivers.Furthermore, we examined quality of life of caregivers, quality of care, service use and costs.

Discussion: This is a unique trial in which we examined the effectiveness of case management from a broad perspective. We meticulously prepared this study and applied important features and created important conditions for both intervention and research protocol to increase the likelihood of finding evidence for the effectiveness of patient advocacy case management. Concerning the intervention we anticipated to five important conditions: 1) the contrast between the case management intervention compared to the usual care seems to be large enough to detect intervention effects; 2) we included patients with complex care situations and/or were at risk for critical situations; 3) the case managers were familiar with disease specific health-problems and a broad spectrum of solutions; 4) case managers were competent and authorized to perform a medical neurological examination and worked closely with neurologists specialized in MS; and 5) the case managers had a regional network of professionals and health care organisations at their disposal, and were accepted as a coordinator of care. We also put a lot of effort on the selection of eligible patients, randomization and statistical methods, but also on power analysis, selection of reliable, validated and sensitive outcome measures, and (statistical) control of confounders.

Trial registration: Dutch Trial Register http://www.trialregister.nl. Trial ID: NTR762.

Figures

Figure 1
Figure 1
Flowchart Dutch patient advocacy case management intervention among severely disabled MS-patients. Summary of the progress through the phases of the study until the allocation of the participants to each treatment arm.

References

    1. Lee DTF, Mackenzie AE, Dudley-Brown S, Chin TM. Case management: a review of the definitions and practices. J Adv Nurs. 1998;27:933–939. doi: 10.1046/j.1365-2648.1998.t01-1-00566.x.
    1. Long MJ. Case management model or case manager type? That is the question. Health Care Manager. 2002;20:53–65.
    1. Casarin SNA, Villa TCS, Gonzales RIC, Freitas MC, Caliri MHL, Sassaki CM. Case management: evolution of the concept in the 80's and 90's. Rev Latino-am Enfermagem. 2002;10:472–477. doi: 10.1590/S0104-11692002000400002.
    1. Meier DE, Thar W, Jordan A, Goldhirsch SL, Siu A, Morrison RS. Integrating case management and palliative care. J Palliat Med. 2004;7:119–134. doi: 10.1089/109662104322737395.
    1. Zwarenstein M, Stephenson B, Johnston L. Case management: effects on professional practice and health care outcomes. (Protocol) The Cochrane Database of Systematic Reviews. 2005;2000:CD002797. DOI:10.1002/1465 1858,CD002797.
    1. Long MJ, Marshall BS. What price an additional day of life? A cost-effectiveness study of case management. Am J Manag Care. 2000;6:881–886.
    1. Long MJ. Cost effectiveness of case management programs for the elderly. Geriatric Times. 2001;II
    1. Hurley RE, Fennell ML. In: Innovations in Health Care Delivery: Insights for Organization Theory. Mick SS, editor. San Francisco: Jossey-Bass Publishers; 1990. Managed-care Systems as Governance Structures: A Transaction-Cost Interpretation; pp. 241–268.
    1. Capitman JA. Case-management for Long-Term Care and Acute Medical Care. Health Care Financ Rev. 1988. pp. 53–55.
    1. Long MJ, Marshall BS. What price an additional day of life? A cost-effectiveness study of case management. Am J Manag Care. 2000;6:881–886.
    1. Pruitt SD, Epping-Jordan JE. Preparing the 21st century global healthcare workforce. Br Med J. 2005;330:637–639. doi: 10.1136/bmj.330.7492.637.
    1. Wynia K, Nissen JMJF, Hoekzema EJ, De Keyser J. Case management for people with a chronic illness. Characteristics of a patient-centred multidisciplinary case management model for people living in the community [Casemanagement voor mensen met een chronische ziekte. Kenmerken van een vraaggericht casemanagement model in een multidisciplinaire en transmurale setting] Verpleegkunde. 2006;21:242–253.
    1. Oeseburg B, Wynia K, Middel B, Reijneveld SA. Effects of case management for frail older people or those with chronic illness: a systematic review. Nurs Res. 2009;58:201–210. doi: 10.1097/NNR.0b013e3181a30941.
    1. Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359:1221–1231. doi: 10.1016/S0140-6736(02)08220-X.
    1. Polit DF, Beck CT. Nursing Research. Principles and Methods. Philadelphia York New, Baltimore: Lippincott; 2004.
    1. Kurtzke JF. Rating Neurologic impairment in Multiple Sclerosis: an Expanded Disability Status Scale (EDSS) Neurology. 1983;33:1444–1452.
    1. Wynia K, Middel B, Van Dijk JP, De Ruiter H, De Keyser J, Reijneveld SA. The Multiple Sclerosis Impact Profile (MSIP). Development and testing psychometric properties of an ICF-based health measure. Disability and rehabilitation. 2008;30:261–274. doi: 10.1080/09638280701256868.
    1. Wynia K, Middel B, Dijk JPv, Ruiter Hd, Lok WS, Keyser JHAd, Reijneveld SA. Adding a subjective dimension to an ICF-based disability measure for people with Multiple Sclerosis. Disabil Rehabil. 2009;31:1008–1017. doi: 10.1080/09638280802509488.
    1. Robinson BC. Validation of a Caregiver Strain Index. J Gerontol. 1983;38:344–348.
    1. The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. Psychological Medicine. 1998;28:551–558. doi: 10.1017/S0033291798006667.
    1. Cardol M, de Haan RJ, Bos GA van den, De Jong BA, de Groot IJ. The development of a handicap assessment questionnaire: the Impact on Participation and Autonomy (IPA) Clin Rehabil. 1999;13:411–419. doi: 10.1191/026921599668601325.
    1. Cardol M, de Haan RJ, De Jong BA, Bos GA van den, de Groot IJ. Psychometric properties of the Impact on Participation and Autonomy Questionnaire. Arch Phys Med Rehabil. 2001;82:210–216. doi: 10.1053/apmr.2001.18218.
    1. Beck AT, Steer RA, Brown GK. Manual for Beck Depression Inventory-II. San Antonio: TX: Psychological Corporation; 1996.
    1. Steer RA, Cavalieri TA, Leonard DM, Beck AT. Use of the Beck Depression Inventory for Primary Care to screen for major depression disorders. Gen Hosp Psychiatry. 1999;21:106–111. doi: 10.1016/S0163-8343(98)00070-X.
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington: DC: Author. 1994.
    1. Wilde EFd, Hendriks VM. The client satisfaction questionnaire: Psychometric properties in a dutch addict population. European Addiction Research. 2005;11:157–162. doi: 10.1159/000086396.
    1. de Brey H. A cross-national validation of the client satisfaction questionnaire: the Dutch experience. Eval Program Plann. 1983;6:395–400. doi: 10.1016/0149-7189(83)90018-6.
    1. Robinson BC. Validation of a Caregiver Strain Index. J Gerontol. 1983;38:344–348.
    1. Wynia K, Middel B, De Ruiter H, Van Dijk JP, De Keyser JHA, Reijneveld SA. Stability and relative validity of the Multiple Sclerosis Impact Profile (MSIP) Disability and rehabilitation. 2008;30:1027–1038. doi: 10.1080/09638280701476193.
    1. Newcombe RG, Altman DG. In: Statistics with confidence. Altman DG, Machin D, Bryant TN, Gardner MJ, editor. Bristol: British Medical Journal; 2005. Proportions and their differences; pp. 45–56.
    1. Cohen J. Statistical power analysis for the behavioural sciences. New York: Academic Press; 1988.
    1. Middel B, Stewart R, Bouma J, van Sonderen E, Heuvel WJA van den. How to validate clinically important change in health-related functional status. Is the magnitude of the effect size consistently related to magnitude of change as indicated by a global question rating? J Eval Clin Pract. 2001;7:399–410. doi: 10.1046/j.1365-2753.2001.00298.x.
    1. Toseland RW, ODonnell JC, Engelhardt JB, Richie J, Jue D, Banks SM. Outpatient geriatric evaluation and management: Is there an investment effect? Gerontologist. 1997;37:324–332.
    1. Newcomer R, Miller R, Clay T, Fox P. Effects of the Medicare Alzheimer's disease demonstration on Medicare expenditures. Health Care Financ Rev. 1999;20:45–65.
    1. Long MJ, Marshall BS. What price an additional day of life? A cost-effectiveness study of case management. Am J Manag Care. 2000;6:881–886.
    1. Toseland RW, ODonnell JC, Engelhardt JB, Richie J, Jue D, Banks SM. Outpatient geriatric evaluation and management: Is there an investment effect? Gerontologist. 1997;37:324–332.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi